Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

Cipla Ltd Q2 FY25 net profit jumped over 15 percent on-year to Rs 1,303 crore, beating Street expectations by a wide margin. A Moneycontrol poll of brokerages had pegged the drugmaker's second ...

Drugmaker Cipla continues to struggle with regulatory challenges which have caused delays in the launch of two key drugs--respiratory medication Advair and chemotherapy drug Abraxane- yet again.

Cipla's consolidated revenue from operations stood at ₹7,051.02 crores during the quarter ended September from ₹6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5%. The firm ...

On the contrary, HSBC has given a 'buy' recommendation on Cipla with the target slashed to Rs 1,755, implying substantial gains of as much as 19 per cent. Jefferies also has reiterated its hold call ...

Cipla Q2 Results Live : Cipla declared their Q2 results on 29 Oct, 2024, showcasing a robust performance with a topline increase of 5.58% year-over-year. The profit surged by 15.18% compared to ...

Pharma major Cipla on Tuesday announced its unaudited consolidated financial results for the quarter ended September 30th, 2024. The company reported an 15.2 percent year-on-year rise in its ...

Q2 Results 2024 highlights: Companies including Maruti Suzuki India, Adani Enterprises, APSEZ, Cipla, Canara Bank, Marico, V-Mart Retail, Force Motors, and many others are releasing Q2 results.

Shares of pharmaceutical major Cipla dropped over 4 per cent on Wednesday at Rs 1,417 per share after analysts highlighted near-term challenges following a muted performance in the second quarter ...

Cipla is currently priced at Rs 1465.90, with a daily change of -2.48%. The 7-day exponential moving average is Rs 1524.88. Cipla shares are currently valued at Rs 1474.75, reflecting a 1.89% drop ...

Cipla has received a new recommendation from Motilal Oswal Financial Services, indicating a potential upside of 31.25%. The target price is set at Rs 1,940.00, while the stock was initially priced at ...

Cipla Ltd.'s consolidated net profit rose 13% in the second quarter of the current financial year, meeting analysts' estimates. The drugmaker posted a profit of Rs 1,305.01 crore in the quarter-ended ...